BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 18700879)

  • 1. Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.
    Campoli M; Ferrone S
    Tissue Antigens; 2008 Oct; 72(4):321-34. PubMed ID: 18700879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Natural Killer and CD8
    Ravindranath MH; Filippone EJ; Devarajan A; Asgharzadeh S
    Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):38-59. PubMed ID: 31009335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevance.
    Chang CC; Ferrone S
    Semin Cancer Biol; 2006 Oct; 16(5):383-92. PubMed ID: 16931041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions.
    Chang CC; Campoli M; Ferrone S
    Adv Cancer Res; 2005; 93():189-234. PubMed ID: 15797448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T and NK cells: two sides of tumor immunoevasion.
    Fruci D; Lo Monaco E; Cifaldi L; Locatelli F; Tremante E; Benevolo M; Giacomini P
    J Transl Med; 2013 Feb; 11():30. PubMed ID: 23379575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
    Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
    Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma.
    Tang XX; Shimada H; Ikegaki N
    Front Immunol; 2021; 12():650427. PubMed ID: 33968044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
    Rouas-Freiss N; Moreau P; Ferrone S; Carosella ED
    Cancer Res; 2005 Nov; 65(22):10139-44. PubMed ID: 16287995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
    Menier C; Riteau B; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell.
    Lesport E; Baudhuin J; LeMaoult J; Sousa S; Doliger C; Carosella ED; Favier B
    Hum Immunol; 2009 Dec; 70(12):1000-5. PubMed ID: 19654030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.
    Rouas-Freiss N; Moreau P; Menier C; LeMaoult J; Carosella ED
    Semin Cancer Biol; 2007 Dec; 17(6):413-21. PubMed ID: 17881247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells.
    Thananchai H; Makadzange T; Maenaka K; Kuroki K; Peng Y; Conlon C; Rowland-Jones S; Dong T
    AIDS; 2009 Jan; 23(2):189-93. PubMed ID: 19098488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rapid induction of HLA-E is essential for the survival of antigen-activated naive CD4 T cells from attack by NK cells.
    Takao S; Ishikawa T; Yamashita K; Uchiyama T
    J Immunol; 2010 Nov; 185(10):6031-40. PubMed ID: 20952676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
    Algarra I; García-Lora A; Cabrera T; Ruiz-Cabello F; Garrido F
    Cancer Immunol Immunother; 2004 Oct; 53(10):904-10. PubMed ID: 15069585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.
    Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF
    Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
    J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.